Cutler Group LP Accelerate Diagnostics, Inc Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$5.31 - $8.25 $12,738 - $19,791	-2,399 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$6.81 - $9.23 $81 - $110	-12 Reduced 0.5%	2,399 $19,000
Q1 2021 Apr 26, 2021	BUY	$7.99 - $15.0 $19,215 - $36,075	2,405 Added 40083.33%	2,411 $20,000
Q4 2020 Jan 21, 2021	BUY	$7.04 - $11.7 $42 - $70	6 New	6 $0
Q1 2020 May 07, 2020	SELL	$4.62 - $18.74 $24,486 - $99,321	-5,300 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$14.6 - $18.13 $77,380 - $96,089	5,300 New	5,300 $89,000
Q4 2018 Feb 05, 2019	SELL	$10.42 - $21.94 $7,294 - $15,358	-700 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$20.4 - $24.6 $20,400 - $24,600	-1,000 Reduced 58.82%	700 $16,000
Q2 2018 Aug 10, 2018	SELL	$19.02 - $24.95 $180,842 - $237,224	-9,508 Reduced 84.83%	1,700 $37,000
Q1 2018 May 11, 2018	BUY	$22.55 - $29.9 $239,571 - $317,657	10,624 Added 1819.18%	11,208 $256,000
Q4 2017 Jan 17, 2018	SELL	$18.0 - $30.0 $80,352 - $133,920	-4,464 Reduced 88.43%	584 $15,000
Q3 2017 Oct 17, 2017	BUY	$21.1 - $25.15 $106,512 - $126,957	5,048	5,048 $113,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.